SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Hurst who wrote (425)6/3/1998 1:55:00 PM
From: Robert DeHaven  Read Replies (2) of 1510
 
I think the important thing to remember is that there is press directing investor's focus on companies involved in finding a vaccine for aids. IMNR did not get mentioned but it'll have its day in the sun. This company is not prone to hyping....I think they'll let the news of trial results speak for them.....I am optimistic of that some positive developments or announcements will come out of the shareholders meeting this month and later at the World Aids conference.

good luck,

bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News